Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Pain medicine (Malden, Mass.)

• Publication date

  2004-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1526-4637.2004.04043.XPMID 15367304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 150 years of Sigmund Freud: what would Freud have said about the obesity epidemic?

  2006cited by this paper
• Anesthetic Pharmacology: Physiologic Principles and Clinical Practice.

  2005cited by this paper
• Anesthetic pharmacology : physiologic principles and clinical practice : a companion to Miller's Anesthesia

  2004cited by this paper
• Morphine-3-Glucuronide’s Neuro-Excitatory Effects Are Mediated via Indirect Activation of N-Methyl-d-Aspartic Acid Receptors: Mechanistic Studies in Embryonic Cultured Hippocampal Neurones

  2003cited by this paper
• Morphine-3β-d-glucuronide Suppresses Inhibitory Synaptic Transmission in Rat Substantia Gelatinosa

  2002cited by this paper
• Successful treatment of a nine-year case of complex regional pain syndrome type-I (reflex sympathetic dystrophy) with intravenous ketamine-infusion therapy in a warfarin-anticoagulated adult female patient.

  2002cited by this paper
• "Sensitization": is there a cure?

  2002cited by this paper
• Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity

  2002cited by this paper
• Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide.

  2001cited by this paper
• An unusual case of chronic neuropathic pain responds to an optimum frequency of intravenous ketamine infusions.

  2001cited by this paper
• A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide.

  2001cited by this paper
• Pain Mechanisms and Management: A Central Perspective

  2000cited by this paper
• Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions.

  2000cited by this paper
• Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor.

  2000cited by this paper
• Automatic and strategic processing of threat cues in patients with chronic pain: a modified stroop evaluation.

  2000cited by this paper
• Neuroexcitatory Effects Of Morphine And Hydromorphone: Evidence Implicating The 3‐Glucuronide Metabolites

  2000cited by this paper
• NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.

  2000cited by this paper
• Effects of oral clonidine premedication on side effects of intravenous ketamine anesthesia: a randomized, double-blind, placebo-controlled study.

  2000cited by this paper
• Changes in pain intensity of post-herpetic neuralgia following intravenous injections of ketamine hydrochloride

  1999cited by this paper
• Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and α2-adrenergic agonists

  1999cited by this paper
• NMDA Receptors and Pain—Hopes for Novel Analgesics

  1999cited by this paper
• [Neuroprotective agents].

  1999cited by this paper
• Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis

  1999cited by this paper
• Clonidine potentiates the neuropathic pain-relieving action of MK-801 while preventing its neurotoxic and hyperactivity side effects.

  1998cited by this paper
• NMDA RECEPTOR ANTAGONISTS

  1998cited by this paper
• The MUltiplicity of Neuropathic Pain Sensations

  1998cited by this paper
• Four years' treatment with ketamine and a trial of dextromethorphan in a patient with severe post‐herpetic neuralgia

  1997cited by this paper
• High‐dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia

  1997cited by this paper
• Multifocal brain damage induced by phencyclidine is augmented by pilocarpine.

  1997cited by this paper
• Oral ketamine therapy in the treatment of postamputation stump pain

  1997cited by this paper
• Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics

  1997cited by this paper
• Activation of N-methyl-D-aspartate receptor attenuates acute responsiveness of delta-opioid receptors.

  1997cited by this paper
• The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input

  1996cited by this paper
• Epidural coadministration of ketamine, morphine and bupivacaine attenuates post-herpetic neuralgia--a case report.

  1996cited by this paper
• Reflex sympathetic dystrophy : a reappraisal

  1996cited by this paper
• Dexmedetomidine Premedication Attenuates Ketamine‐induced Cardiostimulatory Effects and Postanesthetic Delirium

  1995cited by this paper
• Analysis of Drug Interaction between Intrathecal Clonidine and MK‐801 in Peripheral Neuropathic Pain Rat Model

  1995cited by this paper
• Spinal Cord Synaptic Plasticity and Chronic Pain

  1995cited by this paper
• α2 Adrenergic Agonists Prevent MK-801 Neurotoxicity

  1995cited by this paper
• alpha 2 adrenergic agonists prevent MK-801 neurotoxicity.

  1995cited by this paper
• Response of chronic neuropathic pain syndromes to ketamine: a preliminary study

  1994cited by this paper
• The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex.

  1994cited by this paper
• Relief of post‐herpetic neuralgia with the Symbol receptor antagonist ketamine: A double‐blind, cross‐over comparison with morphine and placebo

  1994cited by this paper
• Successful Treatment of Postherpetic Neuralgia with Oral Ketamine

  1994cited by this paper
• Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

  1994cited by this paper
• Pathomorphologic effects of N‐methyl‐D‐aspartate antagonists in the rat posterior ingulate/retrosplenial cerebral cortex: A review

  1994cited by this paper
• Competitive and non-competitive NMDA antagonists induce similar limbic degeneration.

  1994cited by this paper
• Recent advances in chronic pain

  1994cited by this paper
• The induction and maintenance of central sensitization is dependent on N‐methyl‐d‐aspartic acid receptor activation; implications for the treatment of post‐injury pain hypersensitivity states

  1991cited by this paper
• NMDA antagonist neurotoxicity: mechanism and prevention.

  1991cited by this paper
• Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord.

  1990cited by this paper
• Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs.

  1989cited by this paper
• Morphine Tolerance Decreases the Analgesic Effects of Ketamine in Mice

  1988cited by this paper
• Slow dose ketamine - a new technique.

  1981cited by this paper
• Low dose intravenous infusion technique with ketamine

  1980cited by this paper
• Slow Dose Ketamine — A New Technique

  1980cited by this paper
• Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity.

  1979cited by this paper
• Intravenous ketamine for postoperative analgesia.

  1975cited by this paper
• Post‐operative pain relief with ketamine infusion

  1974cited by this paper
• Physiological properties of unmyelinated fiber projection to the spinal cord.

  1966cited by this paper

• To compare the effect of ketamine versus dexmedetomidine spray at the surgical site during closure in lumbar spine fixation surgery for postoperative pain relief: Prospective, randomized, double-blinded, placebo-controlled study.

  2026cites this paper
• Tonic GABA and Glycine Inhibition Control Pain Hypersensitivity via Limiting α2δ-1– and mGluR5–Dependent NMDA Receptor Activity at Primary Afferent→Excitatory Neuron Synapses

  2025cites this paper
• Managing Chronic Pain: The Ketamine Option

  2025cites this paper
• Current and Evolving Concepts in the Management of Complex Regional Pain Syndrome: A Narrative Review

  2025cites this paper
• Psychotic-Like Experiences in Young Recreational Users of Ketamine: A Case Study.

  2025cites this paper
• Ketamine Infusion for Complex Regional Pain Syndrome Treatment: A Narrative Review

  2025cites this paper
• Curcumin alleviates inflammatory effects of ketamine anesthesia in postnatal rats

  2024cites this paper
• Predictive factors of success and failure for intravenous ketamine therapy in patients suffering from chronic neuropathic pain

  2023influential citation
• Comparing the Effects of Low-Dose Ketamine, Fentanyl, and Morphine on Hemorrhagic Tolerance and Analgesia in Humans

  2023cites this paper
• Ketamine for Complex Regional Pain Syndrome: A Narrative Review Highlighting Dosing Practices and Treatment Response.

  2023cites this paper
• Perspectives on the pharmacological management of complex regional pain syndrome

  2023cites this paper
• The complex regional pain syndrome: Diagnosis and management strategies

  2023cites this paper
• NMDA receptors: Biological properties and their roles in neuropsychiatric disorders

  2022cites this paper
• Past-Year Ketamine Use: Evidence from a United States Population, 2015-2019

  2022cites this paper
• Response After Repeated Ketamine Injections in a Rat Model of Neuropathic Pain.

  2022cites this paper
• TIAM1-mediated synaptic plasticity underlies comorbid depression–like and ketamine antidepressant–like actions in chronic pain

  2022cites this paper
• Kétamine et douleur chronique en France : de la théorie à la pratique

  2021cites this paper
• Ketamine for Non-Neuropathic Pain

  2021cites this paper
• Ketamine therapy for chronic pain in The Netherlands: a nationwide survey

  2021cites this paper
• Tiam1-mediated synaptic plasticity drives comorbid depressive symptoms in chronic pain

  2021cites this paper
• Repeated or Continuous Medically Supervised Ketamine Administration Associated with Hepatobiliary Adverse Events: A Retrospective Case Series

  2021cites this paper
• Novel Mechanism for Memantine in Attenuating Diabetic Neuropathic Pain in Mice via Downregulating the Spinal HMGB1/TRL4/NF-kB Inflammatory Axis

  2021cites this paper
• Impact of Ketamine in the Management of Painful Sickle Cell Disease Vaso-Occlusive Crisis

  2021cites this paper
• Use of Ketamine Infusions for Treatment of Complex Regional Pain Syndrome: A Systematic Review

  2021cites this paper
• Complex Regional Pain Syndrome. A Comprehensive Review on Neuroplastic Changes Supporting the Use of Non-invasive Neurostimulation in Clinical Settings

  2021cites this paper
• A systematic review of ketamine for the management of vaso‐occlusive pain in sickle cell disease

  2021cites this paper
• Pharmacologic Treatments for CRPS

  2021cites this paper
• Challenges and Controversies in Complex Regional Pain Syndrome (CRPS) Treatment

  2021cites this paper
• An Analysis of Prolonged, Continuous Ketamine Infusions.

  2021cites this paper
• Separating Fact From Fiction: A Nationwide Longitudinal Examination of Complex Regional Pain Syndrome Following Treatment of Dupuytren Contracture

  2020cites this paper
• Ketamine Infusion: The Wild Wild West (and East).

  2020cites this paper
• Study of Hematological, Biochemical and Histopathological Changes Due to Long-Term Administration of Ketamine in Rat

  2020cites this paper
• Pathophysiologic Approach to Pain Therapy for Complex Pain Entities: A Narrative Review

  2020cites this paper
• Substantial Elevation of Liver Enzymes During Ketamine Infusion: A Case Report.

  2020cites this paper
• Synthesis of ketamine from a nontoxic procedure: a new and efficient route

  2020cites this paper
• A medical mystery of complex regional pain syndrome

  2020cites this paper
• Low Dose Ketamine Infusion for Comorbid Posttraumatic Stress Disorder and Chronic Pain: A Randomized Double-Blind Clinical Trial

  2020cites this paper
• Neuropathic Pain: Complex Regional Pain Syndrome (CRPS)

  2020cites this paper
• 20 Years of Pain Medicine: Documenting Our Progress and the Path Ahead.

  2019cites this paper
• The Pharmacology of Visual Hallucinations in Synucleinopathies

  2019cites this paper
• Algodistrofia (síndrome doloroso regional complejo de tipo I) del pie y del tobillo

  2019cites this paper
• Antinociceptive and antidepressive efficacies of the combined ineffective doses of S-ketamine and URB597

  2019cites this paper
• Dramatic effect in passive ROM exercise under sedation in a patient with intractable complex regional pain syndrome (type I)

  2019cites this paper
• Presynaptic NMDA receptors control nociceptive transmission at the spinal cord level in neuropathic pain

  2019cites this paper
• Pain Pathways and Nervous System Plasticity: Learning and Memory in Pain.

  2019cites this paper
• Algodystrophie (syndrome douloureux régional complexe de type I) du pied et de la cheville

  2019cites this paper
• Intravenous Ketamine Infusion for Complex Regional Pain Syndrome: Survey, Consensus, and a Reference Protocol

  2019cites this paper
• Memantine for the treatment of general neuropathic pain: a narrative review

  2018cites this paper
• The Effect of Ketamine Infusion in the Treatment of Complex Regional Pain Syndrome: a Systemic Review and Meta-analysis

  2018cites this paper
• [Ketamine and chronic pain: A narrative review of its efficacy and its adverse events].

  2018cites this paper
• Effectiveness of Electromagnetic Field Therapy in Upper Extremity Complex Regional Pain Syndrome Type I: a randomized controlled study

  2018cites this paper
• Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists

  2018cites this paper
• Ketamine exposure demographics and outcomes over 16 years as reported to US poison centers

  2018cites this paper
• A reappraisal of the mechanisms of action of ketamine to treat complex regional pain syndrome in the light of cortical excitability changes.

  2018cites this paper
• Study of Hematological, Biochemical and Histopathological Changes Due to Long-Term Administration of Ketamine in Rat

  2018cites this paper
• Three-phase Bone Scintigraphy Can Predict the Analgesic Efficacy of Ketamine Therapy in CRPS

  2018cites this paper
• Improvement in CRPS After Deep Dry Needling Suggests a Role in Myofascial Pain.

  2018cites this paper
• Case Report: Utility of Ketamine, Lidocaine, and Mexiletine as Nonopioid Adjuvants in Complex Cancer-Associated Pain

  2018cites this paper
• Brain Metabolites and Peripheral Biomarkers Associated with Neuroinflammation in Complex Regional Pain Syndrome Using [11C]-(R)-PK11195 Positron Emission Tomography and Magnetic Resonance Spectroscopy: A Pilot Study

  2018cites this paper
• Botulinum toxin Compression sleeve Dorsal root ganglion stimulation Electroconvulsive therapy Intrathecal adenosine Intrathecal baclofen Intrathecal clonidine Intrathecal corticosteroid Intravenous immunoglobulin Intravenous magnesium Movement representation techniques (e.g., action observation, mir

  2017cites this paper
• Case Study of High-Dose Ketamine for Treatment of Complex Regional Pain Syndrome in the Pediatric Intensive Care Unit.

  2017cites this paper
• Ketamine Infusions for Treatment Refractory Headache

  2017cites this paper
• Hallucinogen Persisting Perception Disorder Following Therapeutic Ketamine: A Case Report

  2017cites this paper
• NMDA Receptors and Signaling in Chronic Neuropathic Pain

  2017cites this paper
• PROLONGED ADMINISTRATION OF NMDA ANTAGONST AND SAFENER DRUG TO ALTER NEUROPATHIC PAIN CONDITION ( 76 ) Inventors :

  2017cites this paper
• Recurrent Subanesthetic Ketamine Infusions for Complex Regional Pain Syndrome Leading to Biliary Dilation, Jaundice, and Cholangitis: A Case Report.

  2017cites this paper
• Pain in the Complex Regional Pain Syndrome Rehabilitation Patient

  2017cites this paper
• Efficient Treatment for Complex Regional Pain Syndrome: A Critical Review.

  2017cites this paper
• Ketamine-Induced Mania During Treatment for Complex Regional Pain Syndrome.

  2017cites this paper
• Intravenous Ketamine Infusions for Neuropathic Pain Management: A Promising Therapy in Need of Optimization

  2017cites this paper
• Effects of ketamine constant rate infusions on cardiac biomarkers and cardiac function in dogs.

  2017cites this paper
• Neuromodulation in Treating Complex Regional Pain Syndrome: A Critical Review of the Evidence

  2017cites this paper
• Effect of ketamine combined with magnesium sulfate in neuropathic pain patients (KETAPAIN): study protocol for a randomized controlled trial

  2017cites this paper
• Acupuncture for the Treatment of Peripheral Neuropathy: A Systematic Review and Meta-Analysis

  2017cites this paper
• 40 – Diagnosis and Treatment of Complex Regional Pain Syndrome

  2017cites this paper
• A Pilot Study of the Pharmacogenetics of Ketamine-Induced Emergence Phenomena: A Dissertation

  2016cites this paper
• Role of ketamine for analgesia in adults and children

  2016cites this paper
• Arylcyclohexamines: Ketamine, Phencyclidine, and Analogues

  2016cites this paper
• Ketamine: 50 Years of Modulating the Mind

  2016cites this paper
• HIV/AIDS Neuropathy

  2016cites this paper
• The effects of an intraperitoneal single low dose of ketamine in attenuating the postoperative skin/muscle incision and retraction-induced pain related to the inhibition of N-methyl-D-aspartate receptors in the spinal cord.

  2016cites this paper
• Results of the Treatment of Chronic, Refractory CRPS with Ketamine Infusions: a Preliminary Report

  2016cites this paper
• The effectiveness of transcutaneous electrical nerve stimulation in the management of patients with complex regional pain syndrome: A randomized, double-blinded, placebo-controlled prospective study

  2016cites this paper
• Rapid treatment-induced brain changes in pediatric CRPS

  2016cites this paper
• Kétamine par voie orale pour le traitement du syndrome douloureux régional complexe réfractaire d’une patiente âgée de 36 ans

  2016cites this paper
• Intravenous Therapies for Complex Regional Pain Syndrome: A Systematic Review

  2016cites this paper
• Importance of Pharmacological Evaluation in the Treatment of Poststroke Pain by Spinal Cord Stimulation

  2016cites this paper
• NEUROPATHIC PAIN SECTION

  2016cites this paper
• Changes of lidocaine concentration and physiological indices in dogs during anaesthesia with lidocaine and isoflurane combined with ketamine or fentanyl

  2016cites this paper
• Efficacy and safety of oral ketamine for the relief of intractable chronic pain: A retrospective 5‐year study of 51 patients

  2015cites this paper
• A systematic review of ketamine for complex regional pain syndrome.

  2015cites this paper
• Complex Regional Pain Syndrome (CRPS) / Reflex Sympathetic Dystro..

  2015cites this paper
• CNS Measures of Pain Responses Pre- and Post-Anesthetic Ketamine in a Patient with Complex Regional Pain Syndrome.

  2015cites this paper
• Spinal Cord Stimulation

  2015cites this paper
• The hippocampus and TNF: Common links between chronic pain and depression.

  2015cites this paper
• Nitrous Oxide for the Treatment of Chronic Low Back Pain

  2015cites this paper
• Analgesic Response to Intravenous Ketamine Is Linked to a Circulating microRNA Signature in Female Patients With Complex Regional Pain Syndrome.

  2015cites this paper
• Chapter 1. General introduction

  2015cites this paper
• Applications of Neuromodulation in Pain Management

  2015cites this paper
• Systematic mechanism-orientated approach to chronic pancreatitis pain.

  2015cites this paper